March 22, 2021 05:34 AM EDTUpdated 10:10 AM

AstraZeneca readies April EUA filing with 79% vaccine efficacy, first glimpse of elderly data and 100% protection against severe disease in US trial

Weeks into a chaotic vaccine rollout in Europe, AstraZeneca finally has the long-awaited Phase III data it needs to crack open the American market …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

As­traZeneca read­ies April EUA fil­ing with 79% vac­cine ef­fi­ca­cy, first glimpse of el­der­ly da­ta and 100% pro­tec­tion against se­vere dis­ease in US tri­al